Stocks

3 Low-Risk Dividend Stocks Boasting Attractive Yields and Sustainable Payouts

Published August 28, 2024

For investors seeking a balance of stability and income, dividend-paying stocks are often a go-to choice. Specifically, stocks that not only offer high yields but also maintain sustainable payout ratios — ideally, below 75% — are seen as prime candidates for a low-risk investment strategy. Three such stocks that fit this description and stand out in the earning arena are Chevron Corporation CVX, AT&T Inc. T, and Bristol Myers Squibb BMY. Each company not only provides a solid dividend yield but also operates within industries that offer consistent demand, potentially making them a stronghold in any investment portfolio.

Chevron Corporation: A Titan in Energy

CVX is a giant in the energy sector, with its roots tracing back to Standard Oil. Headquartered in San Ramon, California, Chevron has a presence in over 180 countries, signifying a global reach that supports its market position. The company's operations span the entire oil and natural gas value chain, including exploration, production, refining, and sale of chemicals. With a responsible payout ratio and a tradition of yielding generous dividends, CVX is poised to provide both growth and income to shareholders.

The Telecom Giant: AT&T Inc.

T holds the crown as the world's largest telecommunications company, with a significant footprint in mobile telephone services. Despite the competitive nature of the telecommunications industry, T's diversified business operations and vast network infrastructure suggest a capacity to maintain steady dividend outputs. The company's headquarters in Dallas, Texas, serve as a central hub for innovation and strategy in the increasingly digital and connected world, which can contribute to a sustainable growth trajectory over the long term.

Bristol Myers Squibb: Innovating in Pharmaceuticals

In the pharmaceutical sector, BMY marks its presence with a portfolio aimed at addressing critical therapeutic areas such as cancer, AIDS, and cardiovascular diseases. Based in New York City, Bristol Myers Squibb's commitment to innovation and a strong pipeline of drugs are integral aspects of the company's foundation. These factors, combined with BMY's disciplined approach to maintaining a lower payout ratio, allow for a dividend that is likely to be both reliable and lucrative for the investor focused on stable income streams.

income, dividend, growth